Clinical data | |
---|---|
Trade names | Moderil, Cinnasil, Anaprel |
Routes of administration |
oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.042.232 |
Chemical and physical data | |
Formula | C35H42N2O9 |
Molar mass | 634.716 g/mol |
3D model (JSmol) | |
|
|
|
|
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is an vinca alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia.
Moderil, Cinnasil, Anaprel